BlueRock Therapeutics Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BlueRock Therapeutics's estimated annual revenue is currently $85.7M per year.(i)
  • BlueRock Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • BlueRock Therapeutics has 553 Employees.(i)
  • BlueRock Therapeutics grew their employee count by 33% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.2M10%N/AN/A
#3
$4.2M2735%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$1.4M929%N/AN/A
#6
$235M255-31%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.3M340%N/AN/A
#10
$1.9M12-8%N/AN/A
Add Company

BlueRock Therapeutics is a next-generation regenerative medicine company focused on breakthrough stem cell technology treatments of cardiovascular and neurodegenerative diseases. BlueRock Therapeutics has launched with the backing of a combined $225 million investment by Bayer and biotechnology investment firm Versant Ventures. BlueRock’s initial programs will focus on induced pluripotent stem cell (iPSC)-derived therapeutics to expand their technology pipeline.

keywords:N/A

N/A

Total Funding

553

Number of Employees

$85.7M

Revenue (est)

33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BlueRock Therapeutics News

2022-03-30 - Bayer reloads Leaps with €1.3 billion to step up investments in ...

In 2019, Bayer fully acquired BlueRock Therapeutics, a cell therapy developer it had formed three years earlier as a joint venture with...

2022-03-30 - Leaping forward: Bayer VC arm commits $1.4B to double investment ...

Some of Leaps' bets so far have been in cell therapy, including BlueRock Therapeutics, which Bayer eventually fully acquired for up to $600 million in 2019.

2022-03-30 - Bayer on keeping CGT acquisitions at arm's length - BioProcess ...

... innovation for cell and gene therapies, says Bayer's Jens Vogel. ... when it bought out cell therapy developer BlueRock Therapeutics.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$101M55712%N/A
#2
$173.3M55718%$86.9M
#3
$154.6M56213%N/A
#4
$73.4M56746%$2B
#5
$150.2M5727%N/A